Correction to: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer (British Journal of Cancer, (2024), 131, 6, (1092-1105), 10.1038/s41416-024-02810-8)

Razia Rahman, Muhammed H. Rahaman, Adrienne R. Hanson, Nicholas Choo, Jianling Xie, Scott L. Townley, Raj Shrestha, Ramin Hassankhani, Saiful Islam, Susanne Ramm, Kaylene J. Simpson, Gail P. Risbridger, Giles Best, Margaret M. Centenera, Steven P. Balk, Ganessan Kichenadasse, Renea A. Taylor, Lisa M. Butler, Wayne D. Tilley, Simon J. ConnMitchell G. Lawrence, Shudong Wang, Luke A. Selth

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: British Journal of Cancer (2024) 131:1092-1105; https://doi.org/10.1038/s41416-024-02810-8, published online 08 August 2024 In this article the title was incorrectly given as “CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer” but should have been “CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer”. The original article has been corrected.

Original languageEnglish
JournalBritish Journal of Cancer
DOIs
Publication statusAccepted/In press - 2024

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this